Primus Pharmaceuticals
Clinical trials sponsored by Primus Pharmaceuticals, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New twist on old muscle relaxant aims to ease sciatica pain in days Results expected Nov 2026 (estimated)
- Can a lower dose of a muscle relaxant keep people steadier on their feet? Results expected Jan 2027 (estimated)
- Could a citrus compound heal scleroderma finger ulcers? Results expected Jul 2027 (estimated)
-
New twist on old muscle relaxant aims to ease sciatica pain in days
Symptom relief Recruiting nowThis study tests whether a modified version of the muscle relaxant metaxalone (640 mg) can reduce low back and leg pain in people with acute sciatica or spinal stenosis. Fifty adults aged 18 to 80 with new-onset pain will take either the drug or a placebo for 7 days. Researchers …
Phase 4 • Sponsor: Primus Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Could a citrus compound heal scleroderma finger ulcers?
Symptom relief Recruiting nowThis study tests whether diosmin, a citrus-based supplement, can safely heal open sores on the fingers of people with scleroderma. About 45 adults with at least one active digital ulcer will take either diosmin or a placebo for 8 weeks. Researchers will track ulcer healing, pain,…
Sponsor: Primus Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC